The number of individuals suffering from alcoholic liver diseases has witnessed exponential growth over the past two decades and as per current trends, numbers are expected to further grow at a rapid pace. Of various alcoholic liver diseases, alcoholic hepatitis has considerably higher mortality and morbidity rate. In addition, the financial and healthcare burden caused due to alcoholic hepatitis continues to move in the upward curve. Over the past decade, a huge amount of research and development activities has been carried out to improve diagnostic care and quality of treatments.
Research and development activities have revealed that modification of gut microbiota and products related to it, including nutritional intervention, increasing steroid sensitivity, lipopolysaccharide, immune modulation, and epigenetic modification of liver damage caused by alcohol are some of the groundbreaking avenues in the alcoholic hepatitis therapeutics market that are expected to offer tremendous promise during the forecast period. At present, with increasing knowledge pertaining to pathophysiology, new treatment alternatives for alcoholic hepatitis are expected to make an entry into the alcoholic hepatitis therapeutics market.
At the back of these factors, along with growing investments for R&D activities, the global alcoholic hepatitis therapeutics market is expected to reach ~US$ 1.2 Bn by the end of 2030.
The global burden of alcoholic related diseases continues to grow at a rampant pace. According to the World Health Organization, nearly half a million deaths were reported in 2016 that were linked to alcohol-related cirrhosis. At present, companies in the alcoholic hepatitis therapeutics market are primarily focusing on attaining future therapeutic targets by investing in drug development and research activities. The socioeconomic status of different regions of the world is another major factor that has played a key role in dictating the prevalence of alcohol-related digestive diseases.
Some of the most extensively used treatment alternatives available in the alcoholic hepatitis therapeutics market include pentoxifylline, nutritional therapy, anabolic steroids, and hemorheological agents. Advancements in technology and basic sciences have increased the overall understanding of the pathogenesis of alcoholic liver diseases due to which, the prospects of the alcoholic hepatitis therapeutics market are staring at a bright future. One of the most widely used therapy for alcoholic hepatitis is enteral nutrition and abstinence. Although anabolic steroids are available as an effective treatment option, the adoption of the same is largely hindered due to the side effects.
The advent of the novel COVID-19 pandemic has played a critical role in influencing the overall operations across the healthcare sector. While the pressure remains high to discover a vaccine or drug to treat the novel coronavirus, research activities pertaining to the development of alcoholic hepatitis therapeutics are likely to take a hit amid the ongoing health crisis. Investments are likely to delay along with potential delays in the development of new drugs and therapies. While the market in the first quarter of 2020 was largely affected by the lockdown imposed by the Chinese Government, the second and third quarters are expected to witness considerable bottlenecks across the supply chain due to restrictions on cross-border trade and transportation.
The global alcoholic hepatitis therapeutics market is expected to witness slower growth compared to the growth in 2019. However, as governments around the world gradually ease down lockdown regulations, the alcoholic hepatitis therapeutics market is likely to witness considerable activity toward the last quarter of 2020.
Analysts’ Viewpoint
The global alcoholic hepatitis therapeutics market is expected to grow at a healthy CAGR of ~6% during the forecast period. The market growth can be primarily attributed to the high prevalence of alcohol-related diseases worldwide, emphasis on the development of new therapies, and consistent growth in the number of research and development projects, among others. Market players are anticipated to focus on research activities and collaborate with small- and medium-sized market participants in different regions to expand their presence in the current market landscape. While the COVID-19 pandemic is projected to disrupt operations, product diversification should remain an area of interest.
Alcoholic Hepatitis Therapeutics Market – Segmentation
TMR’s study on the global alcoholic hepatitis therapeutics market includes information divided into four segments: treatment, application, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global alcoholic hepatitis therapeutics market are discussed in detail.
|
Treatment |
|
|
Application |
|
|
Distribution Channel |
|
|
Region |
|
Alcoholic hepatitis therapeutics market is expected to reach ~US$ 1.2 Bn by the end of 2030
Alcoholic hepatitis therapeutics market is projected to expand at a CAGR of 6% from 2020 to 2030
Alcoholic hepatitis therapeutics market is driven by increase in the number of patients afflicted with the alcoholic liver disease across the globe
The corticosteroids segment dominated the global alcoholic hepatitis therapeutics market, this trend is projected to continue during the forecast period
Key players operating in the global alcoholic hepatitis therapeutics market include Gilead Sciences, Inc., Sanofi, Generon Pharmaceutical Technology (Shanghai) Co., Ltd., Immuron Ltd., and Intercept Pharmaceuticals, Inc.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
3. Executive Summary
3.1. Global Alcoholic Hepatitis Therapeutics Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Market Dynamics
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Key Trends
4.4. Global Alcoholic Hepatitis Therapeutics Market Revenue Projection
4.5. Global Alcoholic Hepatitis Therapeutics Market Outlook
5. Market Outlook
5.1. COVID-19 Pandemic Impact on Global Alcoholic Hepatitis Therapeutics Industry
5.2. Regulatory Scenario, by Region/globally
5.3. Health Care Overview
5.4. Pipeline Analysis
5.5. Epidemiology of Alcoholic Liver Diseases
5.6. Overview of Alcoholic Hepatitis
6. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment
6.1. Introduction
6.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
6.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
6.3.1. Corticosteroids
6.3.2. Hemorrheologic Agents
6.3.3. Anabolic Steroids
6.3.4. Others
6.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment
7. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application
7.1. Introduction
7.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
7.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Application
7.3.1. Mild
7.3.2. Severe/Chronic
7.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application
8. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel
8.1. Introduction
8.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
8.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel
9. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Region
9.1. Global Alcoholic Hepatitis Therapeutics Market Scenario, by Country
9.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Region
9.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Alcoholic Hepatitis Therapeutics Market Analysis
10.1. North America Alcoholic Hepatitis Therapeutics Market Analysis
10.2. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
10.3. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
10.3.1. Corticosteroids
10.3.2. Hemorrheologic Agents
10.3.3. Anabolic Steroids
10.3.4. Others
10.4. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
10.5. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Application
10.5.1. Mild
10.5.2. Severe/Chronic
10.6. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
10.7. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
10.7.1. Hospital Pharmacies
10.7.2. Retail Pharmacies
10.7.3. Online Pharmacies
10.8. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country
10.9. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Country
10.9.1. U.S.
10.9.2. Canada
11. Europe Alcoholic Hepatitis Therapeutics Market Analysis
11.1. Europe Alcoholic Hepatitis Therapeutics Market Analysis
11.2. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
11.3. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
11.3.1. Corticosteroids
11.3.2. Hemorrheologic Agents
11.3.3. Anabolic Steroids
11.3.4. Others
11.4. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
11.5. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Application
11.5.1. Mild
11.5.2. Severe/Chronic
11.6. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
11.7. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
11.7.1. Hospital Pharmacies
11.7.2. Retail Pharmacies
11.7.3. Online Pharmacies
11.8. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.9. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
11.9.1. U.K.
11.9.2. Germany
11.9.3. France
11.9.4. Spain
11.9.5. Italy
11.9.6. Rest of Europe
12. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis
12.1. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis
12.2. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
12.3. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
12.3.1. Corticosteroids
12.3.2. Hemorrheologic Agents
12.3.3. Anabolic Steroids
12.3.4. Others
12.4. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
12.5. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Application
12.5.1. Mild
12.5.2. Severe/Chronic
12.6. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
12.7. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
12.7.1. Hospital Pharmacies
12.7.2. Retail Pharmacies
12.7.3. Online Pharmacies
12.8. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.9. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
12.9.1. Australia & New Zealand
12.9.2. Japan
12.9.3. China
12.9.4. India
12.9.5. Rest of Asia Pacific
13. Latin America Alcoholic Hepatitis Therapeutics Market Analysis
13.1. Latin America Alcoholic Hepatitis Therapeutics Market Analysis
13.2. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
13.3. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
13.3.1. Corticosteroids
13.3.2. Hemorrheologic Agents
13.3.3. Anabolic Steroids
13.3.4. Others
13.4. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
13.5. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Application
13.5.1. Mild
13.5.2. Severe/Chronic
13.6. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
13.7. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
13.7.1. Hospital Pharmacies
13.7.2. Retail Pharmacies
13.7.3. Online Pharmacies
13.8. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.9. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
13.9.1. Brazil
13.9.2. Mexico
13.9.3. Rest of Latin America
14. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis
14.1. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis
14.2. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
14.3. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
14.3.1. Corticosteroids
14.3.2. Hemorrheologic Agents
14.3.3. Anabolic Steroids
14.3.4. Others
14.4. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
14.5. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Application
14.5.1. Mild
14.5.2. Severe/Chronic
14.6. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
14.7. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
14.7.1. Hospital Pharmacies
14.7.2. Retail Pharmacies
14.7.3. Online Pharmacies
14.8. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.9. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
14.9.1. GCC Countries
14.9.2. South Africa
14.9.3. Rest of Middle East & Africa
15. Competitive Landscape
15.1. Company Profile
15.1.1. Gilead Sciences, Inc.
15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.1.2. Financial Overview
15.1.1.3. Product Portfolio
15.1.1.4. SWOT Analysis
15.1.1.5. Strategic Overview
15.1.2. Sanofi
15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.2.2. Financial Overview
15.1.2.3. Product Portfolio
15.1.2.4. SWOT Analysis
15.1.2.5. Strategic Overview
15.1.3. Generon Pharmaceutical Technology (Shanghai) Co., Ltd.
15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.3.2. Financial Overview
15.1.3.3. Product Portfolio
15.1.3.4. SWOT Analysis
15.1.3.5. Strategic Overview
15.1.4. Immuron Ltd.
15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.4.2. Product Portfolio
15.1.4.3. SWOT Analysis
15.1.4.4. Strategic Overview
15.1.5. Intercept Pharmaceuticals, Inc.
15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.1.5.2. Financial Overview
15.1.5.3. Product Portfolio
15.1.5.4. SWOT Analysis
15.1.5.5. Strategic Overview
List of Tables
Table 01: Alcohol, total per capita (15+) consumption (in liters of pure alcohol) with 95%CI, by Country, 2016
Table 02: Epidemiology of Covid-19 Country/Sub-region
Table 03: Gross Domestic Product (GDP), by Country, 2014-2017
Table 04: Pipeline Analysis of Alcoholic Hepatitis Therapeutics
Table 05: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 06: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 07: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 08: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018–2030
Table 10: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Application, 2018–2030
Table 11: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 12: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 13: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Treatment, 2018–2030
Table 14: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Application, 2018–2030
Table 15: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 16: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17: Asia Pacific Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018–2030
Table 18: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 19: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 20: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 21: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 22: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 23: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 24: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 25: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018–2030
Table 26: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 27: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 28: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
List of Figures
Figure 01: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2019 and 2030
Figure 02: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, 2018–2030
Figure 03: Market Value Share, by Treatment, 2019
Figure 04: Market Value Share, by Application, 2019
Figure 05: Market Value Share, by Distribution Channel, 2019
Figure 06: Market Value Share, by Region, 2019
Figure 07: Regulatory Approval Process - U.S.
Figure 08: Regulatory Approval Process - Europe
Figure 09: Regulatory Approval Process - Japan
Figure 10: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
Figure 11: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020–2030
Figure 12: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2018–2030
Figure 13: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrheologic Agents, 2018–2030
Figure 14: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anabolic Steroids, 2018–2030
Figure 15: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2030
Figure 16: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
Figure 17: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020–2030
Figure 18: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Mild AH, 2018–2030
Figure 19: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Severe/Chronic AH, 2018–2030
Figure 20: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 21: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 22: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2030
Figure 23: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2030
Figure 24: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018–2030
Figure 25: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Region, 2019 and 2030
Figure 26: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Region, 2020¬¬–2030
Figure 27: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 28: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬–2030
Figure 29: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
Figure 30: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬–2030
Figure 31: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
Figure 32: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬–2030
Figure 33: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 34: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country, 2019 and 2030
Figure 35: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country, 2020–2030
Figure 36: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 37: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬-–2030
Figure 38: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
Figure 39: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬–2030
Figure 40: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
Figure 41: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬–2030
Figure 42: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 43: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 44: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 45: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 46: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬–2030
Figure 47: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
Figure 48: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬–2030
Figure 49: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
Figure 50: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬–2030
Figure 51: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 52: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 53: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 54: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 55: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬–2030
Figure 56: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
Figure 57: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬–2030
Figure 58: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
Figure 59: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬–2030
Figure 60: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 61: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 62: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 63 Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 64: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬–2030
Figure 65: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
Figure 66: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬–2030
Figure 67: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
Figure 68: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬–2030
Figure 69: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 70: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 71: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 72: Gilead Sciences, Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2019
Figure 73: Gilead Sciences, Inc., Breakdown of Net Sales, by Region, 2019
Figure 74: Gilead Sciences, Inc., R&D Intensity (%) - Company Level or Segment Level, 2016–2019
Figure 75: Sanofi, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 76: Sanofi, Breakdown of Net Sales, by Business Segment, 2019
Figure 77: Sanofi, Breakdown of Net Sales, by Region, 2019
Figure 78: Immuron, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 79: Immuron, R&D Expenses - Company Level, 2016–2019
Figure 80: Intercept Pharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019
Figure 81: Intercept Pharmaceuticals, Inc., R&D Expenses - Company Level, 2016–2019
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Alcoholic Hepatitis Therapeutics Market
